Extract to table

In that scenario, Cascade must be prepared to negotiate a remedy that satisfies the DOJ's competitive concerns while preserving the maximum strategic and financial value of the Transaction

Financial Profile NovaHome's financial performance must be estimated, as NovaMart does not report segment-level financial results for its individual verticals

The divestiture must be sufficient to restore competition in the relevant market to its pre-merger level

The DOJ must approve the divestiture buyer

This risk must be assessed and mitigated through the viability analysis and by identifying a strong upfront buyer with existing platform capabilities

There is no provision in the SPA that would automatically reduce the purchase price if Cascade is required to divest a portion of NovaMart's business as a regulatory remedy